Skip to main content

Humana income statement

  • HUM · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$450.00+1.42%Close 13 Nov 2026 · Market value $55.10B

Humana reported revenue of $129.7 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 10.1% from fiscal 2024. Net income was $1.19 billion and diluted earnings per share $9.84.

From Humana's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Humana income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$25.29B$28.95B$30.74B$33.60B$36.83B$39.13B$41.31B$48.50B$54.29B$54.38B$53.77B$56.91B$64.89B$77.16B$83.06B$92.87B$106.4B$117.8B$129.7B$154.2B
Revenue growth—+14.5%+6.2%+9.3%+9.6%+6.2%+5.6%+17.4%+11.9%+0.2%−1.1%+5.8%+14.0%+18.9%+7.7%+11.8%+14.5%+10.7%+10.1%—
Selling, general and administrative$3.48B$3.94B$4.01B$4.38B$5.39B$5.83B$6.36B$7.64B$7.29B$7.17B$6.57B$7.53B$7.38B$10.05B$10.12B$12.67B$13.19B$13.70B$15.45B$17.04B
Operating income$1.36B$1.07B$1.71B$1.85B$2.34B$2.02B$2.06B$2.36B$2.35B$1.74B$4.26B$3.10B$3.19B$4.99B$3.15B$3.80B$4.01B$2.56B$2.70B$2.38B
Operating margin5.4%3.7%5.6%5.5%6.4%5.2%5.0%4.9%4.3%3.2%7.9%5.4%4.9%6.5%3.8%4.1%3.8%2.2%2.1%1.5%
Interest expense$68.88M$80.29M$106.0M$105.0M$109.0M$105.0M$140.0M$192.0M$186.0M$189.0M$242.0M$218.0M$242.0M$283.0M$326.0M$401.0M$493.0M$660.0M$631.0M$753.0M
Income before tax$1.29B$992.8M$1.60B$1.75B$2.23B$1.91B$1.92B$2.17B$2.43B$1.55B$4.02B$2.07B$3.47B$4.67B$3.42B$3.57B$3.33B$1.62B$1.44B—
Income tax expense$455.6M$345.7M$562.0M$650.0M$816.0M$689.0M$690.0M$1.02B$1.16B$938.0M$1.57B$391.0M$763.0M$1.31B$485.0M$762.0M$836.0M$413.0M$250.0M$424.0M
Effective tax rate35.3%34.8%35.1%37.2%36.5%36.1%35.9%47.1%47.5%60.4%39.1%18.9%22.0%28.0%14.2%21.4%25.1%25.5%17.4%—
Net income$833.7M$647.2M$1.04B$1.10B$1.42B$1.22B$1.23B$1.15B$1.28B$614.0M$2.45B$1.68B$2.71B$3.37B$2.93B$2.81B$2.49B$1.21B$1.19B$1.25B
Net margin3.3%2.2%3.4%3.3%3.9%3.1%3.0%2.4%2.4%1.1%4.6%3.0%4.2%4.4%3.5%3.0%2.3%1.0%0.9%0.8%
EPS · diluted$4.91$3.83$6.15$6.47$8.46$7.47$7.73$7.36$8.44$4.07$16.81$12.16$20.10$25.31$22.67$22.08$20.00$9.98$9.84$10.28
Diluted weighted average shares170M169M169M170M168M163M159M156M151M151M146M138M135M133M129M127M124M121M121M121M
Basic weighted average shares—167M167M168M165M161M158M154M149M149M144M137M134M132M129M126M124M121M120M120M
EBITDA$1.54B$1.29B$1.96B$2.12B$2.65B$2.35B$2.37B$2.69B$2.70B$2.13B$4.67B$3.54B$3.77B$5.60B$3.74B$4.51B$4.79B$3.40B$3.40B$3.02B
EBITDA margin6.1%4.5%6.4%6.3%7.2%6.0%5.7%5.5%5.0%3.9%8.7%6.2%5.8%7.3%4.5%4.9%4.5%2.9%2.6%2.0%
Depreciation & amortization$184.8M$220.3M$250.0M$263.0M$303.0M$338.0M$309.0M$328.0M$354.0M$388.0M$410.0M$444.0M$575.0M$616.0M$596.0M$709.0M$779.0M$839.0M$698.0M$644.0M
Stock-based compensation$42.13M$55.37M$66.00M$63.00M$67.00M$82.00M$92.00M$98.00M$109.0M$115.0M$157.0M$137.0M$163.0M$181.0M$180.0M$216.0M$175.0M$207.0M$241.0M$231.0M
Dividends per share———$0.00$0.75$1.03$1.07$1.11$1.14$1.16$1.49$1.90$2.15$2.43$2.73$3.06$3.44$3.54$3.54$3.54

Quarterly

Humana income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$26.46B$29.61B$29.54B$29.40B$29.21B$32.11B$32.39B$32.65B$32.52B$39.65B$40.87B$41.16B
Selling, general and administrative$3.83B$3.04B$3.15B$3.34B$4.17B$3.38B$3.55B$4.08B$4.44B$4.02B$3.98B$4.60B
Operating income−$348.0M$1.24B$1.14B$728.0M−$543.0M$2.01B$1.10B$400.0M−$808.0M$1.75B$1.36B$75.00M
Operating margin−1.3%4.2%3.9%2.5%−1.9%6.3%3.4%1.2%−2.5%4.4%3.3%0.2%
Interest expense$146.0M$159.0M$168.0M$169.0M$164.0M$160.0M$157.0M$168.0M$146.0M$193.0M$197.0M$217.0M
Income before tax−$610.0M$990.0M$901.0M$635.0M−$906.0M————$1.59B$952.0M$216.0M
Income tax expense−$75.00M$251.0M$223.0M$155.0M−$216.0M$406.0M$179.0M−$86.00M−$249.0M$395.0M$238.0M$40.00M
Effective tax rate12.3%25.4%24.8%24.4%23.8%————24.8%25.0%18.5%
Net income−$541.0M$741.0M$679.0M$480.0M−$693.0M$1.24B$545.0M$195.0M−$796.0M$1.19B$694.0M$162.0M
Net margin−2.0%2.5%2.3%1.6%−2.4%3.9%1.7%0.6%−2.4%3.0%1.7%0.4%
EPS · diluted−$4.39$6.11$5.62$3.98−$5.74$10.30$4.51$1.62−$6.58$9.83$5.73$1.33
Diluted weighted average shares123M121M121M121M121M121M121M121M121M121M121M122M
Basic weighted average shares122M121M120M120M120M121M121M120M120M120M120M120M
EBITDA−$147.0M$1.45B$1.35B$938.0M−$335.0M$2.20B$1.28B$573.0M−$644.0M$1.92B$1.52B$233.0M
EBITDA margin−0.6%4.9%4.6%3.2%−1.1%6.8%3.9%1.8%−2.0%4.8%3.7%0.6%
Depreciation & amortization$201.0M$209.0M$212.0M$210.0M$208.0M$183.0M$178.0M$173.0M$164.0M$163.0M$159.0M$158.0M
Stock-based compensation$33.00M$45.00M$55.00M$53.00M$54.00M$49.00M$61.00M$83.00M$48.00M$51.00M$65.00M$67.00M
Dividends per share—$0.89$0.89$0.89$0.88$0.89$0.89$0.89$0.88$0.89$0.89$0.89

The main figures as JSON and plain text. See data and methodology.

HUM in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.